Trial Details
TERMINATEDBasic Information
| Clinical ID | c1881 |
|---|---|
| Identifier | NCT03358407 |
| Trial Title | GSK2983559 First Time in Human Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: GSK2983559; DRUG: Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Cambridge |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-01-11 |
|---|---|
| Primary Completion Date | 2019-02-19 |
| Completion Date | 2019-02-19 |